The Duke Human Vaccine Institute
ResearchView the employees at
The Duke Human Vaccine Institute-
Michelle Rock Senior Research Analyst at Duke Human Vaccine Institute
-
Washington DC-Baltimore Area
-
Rising Star
Paul M. Hargarten Biostatistician III, Duke Human Vaccine Institute-
Top 5%
Gary Massey Accessioning Unit Manager Duke Human Vaccine Institute-
Durham, North Carolina, United States
-
Rising Star
Margarette Donnay CCRP Research Administration; Clinical Research Financial Management; Sponsored Programs; CTMS; SOPs; Clinical Trial Billing Compliance; Federal Grants; CFR; IRB; GCP/ICH; FDA-
Dallas, Texas, United States
-
Top 5%
Kailie Montanez NGS Molecular Scientist, Lab Analyst-
Wake Forest, North Carolina, United States
-
Rising Star
Overview
The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases. DHVI plays an integral leadership role in the Global HIV/AIDS Vaccine Enterprise and is a pioneer in emerging infections and biodefense research. By focusing on the scientific “bottlenecks” for the development of HIV, influenza, SARS-CoV-2, and other vaccines and therapeutics, DHVI investigators continue to make significant contributions to overcome global health challenges on behalf of society. Our Mission: To develop vaccines and therapeutics against diseases of global importance while training the next generation of scientists. Our Values: The DHVI supports the development of vaccines and therapeutics through a commitment to Innovation, Collaboration, and Excellence. Excellence through a commitment to respect, integrity, and safety Collaboration through embracing change and cultivating diversity to achieve synergy Innovation through ingenuity and the pursuit of continuous improvement
-